April 27, 2025 Asembia Specialty Pharmacy Summit 2025 2025 Asembia Conference IntegriChain is a proud silver sponsor and exhibitor at this year’s Asembia Specialty Pharmacy Summit, April 27 – May 1, 2025 at the Wynn & Encore in Las Vegas. We look forward to welcoming attendees to booth 1424 during the show to discuss the ways IntegriChain connects the commercial, financial, and operational dimensions of drug access and profitability, from strategy to operational execution. Brett CasperSenior Principal Date/Time: Monday, April 28 at 2:00 PM Session: Commercialization Considerations for Orphan/Rare, Cell and Gene, and Precision Medicine Description: Manufacturers of Orphan/Rare, Cell and Gene, and Precision Therapies must navigate a host of marketplace complexities for product commercialization. This session identifies and brings clarity to the most pressing challenges manufacturers are facing – and having difficulty navigating – in today’s market. Specific emphasis will be on patient identification, customer experience, site of administration, and data collection/utilization. Richard PrestSenior Principal Date/Time: Tuesday, April 29 at 1:00 PM Session: Advanced Therapies and the FDA: Medicine of the Future Meets the Healthcare System of Today Moderator: Richard Prest, Senior Principal, Blue Fin Group Panelist: Fran Gregory, Vice President, Emerging Therapies, Cardinal Health Description: This session will provide an overview of the current state of cell and gene therapies, and how the FDA views these complex therapies from a regulatory and patient impact standpoint. We will discuss challenges from the commercialization perspective, such as payer and provider acceptance. We will also discuss the provider experience and discuss how CGT’s can benefit patients but also challenge sites of care in new ways.
